Harley I. Kornblum

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• <b>Acute rapamycin treatment reveals novel mechanisms of dysfunction in a maternal inflammation mouse model</b>

  Figshare · 2026-04-17

• <b>Acute rapamycin treatment reveals novel mechanisms of dysfunction in a maternal inflammation mouse model</b>

  Figshare · 2026-04-17

• Acute rapamycin treatment reveals novel mechanisms of dysfunction in a maternal inflammation mouse model

  Zenodo (CERN European Organization for Nuclear Research) · 2026-04-14

• Acute rapamycin treatment reveals novel mechanisms of dysfunction in a maternal inflammation mouse model

  Zenodo (CERN European Organization for Nuclear Research) · 2026-04-14

• Abstract 6234: Characterizing the competitive interactions between glioblastoma and oligodendrocyte progenitor cells

  Cancer Research · 2026-04-03

• Temporal Mapping of Radiation-Induced Neural Injury and Mitigation in Human Cortical Organoids

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-06

• Critical role of cell competition in gliomagenesis

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-01-16

• Supplementary Table S3 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Table S9 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Table S2 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Table S4 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Table S6 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S7 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S5 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S3 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S6 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S8 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Data: list of figures and tables from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S4 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11

• Supplementary Figure S2 from &lt;i&gt;(R)&lt;/i&gt;-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in &lt;i&gt;IDH&lt;/i&gt;-Mutant Cancers

  2025-12-11